...
首页> 外文期刊>Bioconjugate Chemistry >Design, Synthesis, and Biological Evaluation of New Cathepsin B-Sensitive Camptothecin Nanoparticles Equipped with a Novel Multifuctional Linker
【24h】

Design, Synthesis, and Biological Evaluation of New Cathepsin B-Sensitive Camptothecin Nanoparticles Equipped with a Novel Multifuctional Linker

机译:配备新型多功能连接子的新型组织蛋白酶B敏感性喜树碱纳米颗粒的设计,合成和生物学评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Traditional antitumor drugs such as camptothecin and paclitaxel derivatives are widely used in cancer chemotherapy. However, the major defects of those agents include severe toxicity and poor water solubility. With these in mind, a novel multifunctional linker was designed and two Cathepsin B (CTB) sensitive CPT conjugates (9a and 9b) were synthesized. Through click chemistry, additional functional group mPEG(2000) can be easily introduced into these conjugates. The introduction of mPEG(200)0 fragment resulted in the formation of nanoparticles 1a and 1b (average particle sizes were 216.9 and 257.9 nm, respectively) with significantly increased water solubility (more than 19 000-fold). The release of therapeutic drug SN-38 in the presence of CTB was confirmed by HPLC and prodrug la showed potent in vitro cytotoxicity against all tested cell lines. Impressively, compared with irinotecan, CTB sensitive prodrug la displayed similar in vivo efficacy with remarkable decreased in vivo toxicity.
机译:传统的抗肿瘤药物如喜树碱和紫杉醇衍生物广泛用于癌症化疗。但是,这些试剂的主要缺陷包括严重的毒性和较差的水溶性。考虑到这些,设计了新颖的多功能接头,并合成了两个组织蛋白酶B(CTB)敏感的CPT偶联物(9a和9b)。通过单击化学,可以将其他官能团mPEG(2000)轻松引入这些偶联物中。 mPEG(200)0片段的引入导致纳米粒子1a和1b的形成(平均粒径分别为216.9和257.9 nm),其水溶性大大提高(超过19 000倍)。 HPLC证实在CTB存在下治疗药物SN-38的释放,并且前药1a显示出对所有测试细胞系的有效体外细胞毒性。令人印象深刻的是,与伊立替康相比,CTB敏感的前药1a具有相似的体内功效,体内毒性显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号